SURGICAL SITE INFECTION INCIDENCE AND BURDEN ASSESSMENT USING MULTI-INSTITUTIONAL REAL-WORLD DATA
Author(s)
DeLissovoy G1, Pan F2, Patkar AD3, Edmiston CE4, Peng S21Johns Hopkins Bloomberg School of Public Health, Baltimore , MD, USA, 2United Biosource Corporation, Bethesda, MD, USA, 3Ethicon, Inc, Somerville, NJ, USA, 4Froedtert Hospital, Milwaukee, WI, USA
OBJECTIVES: Surgical site infections (SSIs) are a significant burden to healthcare systems negatively affecting Medicare reimbursement, quality and hospital reputation. This study quantifies the economic impact of SSIs across multiple institutions in the United States (US) using more up-to-date real-world data METHODS: The economic impact of SSIs was evaluated in following surgeries (colon, hernia, CABG, shunt, abdominal and vaginal hysterectomy, c-section, hip and knee prosthesis, spinal fusion, abdominoplasty and breast surgery). The data source was the Premier Perspective™ Comparative Database, a national administrative discharge database (2007-2010) from about 500 hospitals throughout the US. The SSIs were identified by a combination of post-operative infection diagnosis codes, or postoperative prescription of selected antimicrobial drugs with treatment duration ≥5 days. The outcomes included rates of SSI by surgical category, the impact of SSI on length of stay (LOS) and costs. Results were projected to the national level. Generalized linear models were used for the analysis. Covariates included the baseline patient-level surgical risk factors and hospital characteristics. RESULTS: SSI incidence was highest among colon surgery [12.0%, 95%CI:11.78-12.2%0)] and CABG [6.1%; 95%CI:5.88-6.2%)] cases, and lowest among C-section [0.3%; 95%CI:0.28-0.31%)] and vaginal hysterectomy [0.16%; 95%CI:0.13-0.2%)] cases. The projected national rates captured by Premier database were similar to the rates reported by the National Health Safety Network reported rates. Among all surgical procedures, health resource use associated with CABG and colon surgery cases were most affected by SSI. SSI resulted on an average 10.58 [SD 2.78; (95%CI:10.56-10.60)] days and 9.72 [SD 3.43; (95%CI:9.70-9.74)] days of additional LOS and $38,796 [SD $8,555; (95%CI:$38,741-$38,850)] and $19,349 [SD $5,720; (95%CI:$19,315-$19,383)] of additional costs in CABG and colon procedures respectively. CONCLUSIONS: Despite rise in infection control practices postoperative SSIs continue to remain associated with significant increases in LOS and hospitalization costs.
Conference/Value in Health Info
2011-11, ISPOR Europe 2011, Madrid, Spain
Value in Health, Vol. 14, No. 7 (November 2011)
Code
PIN36
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)